🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lipoprotein-associated phospholipase A2 (LP-PLA2) is a good marker of cardi...
Status
Completed
Location
Multiple Locations
Start Date
2015-01-30
Trial ID
NCT03362112
The investigator's hypothesis is that local activation of the endogenous Lp...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01642173
Treatments Being Tested
This study will determine the effect of single and repeat administration of...
Status
Completed
Location
GSK Investigational Site
Start Date
2013-06-19
Trial ID
NCT01873339
Treatments Being Tested
AIM III is a prospective, randomized, double-blinded, placebo controlled tr...
Status
Completed
Location
Mayo Clinic
Start Date
2010-02-04
Trial ID
NCT01067339
Treatments Being Tested
Vascular inflammation is a key factor in both the pathogenesis and outcome ...
Status
Completed
Location
Hye Jin Yoo
Start Date
2009-12
Trial ID
NCT01022684
Treatments Being Tested
The investigators' hypothesis is that local activation of the endogenous Li...
Status
Completed
Location
Mayo Clinic
Start Date
2010-01
Trial ID
NCT01581632
Treatments Being Tested
A blood test (2-3 cc peripheral venous blood) drawn /used from already avai...
Status
Completed
Location
The E.Wolfson MC
Start Date
2010-01
Trial ID
NCT01041339
To assess the association between periodontal parameters, serum lipid profi...
Status
Completed
Location
Multiple Locations
Start Date
2015-02-02
Trial ID
NCT03041480
Treatments Being Tested
The potential for a drug interaction between Darapladib and Rosuvastatin is...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-12-17
Trial ID
NCT01751074
Treatments Being Tested
The objective of this study is to demonstrate that rPAF-AH is safe and redu...
Status
Terminated
Location
Mary E. Lonien, M.S.
Start Date
2001-04
Trial ID
NCT00037687
Treatments Being Tested